IGHID 11417 - PHI 05 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
University of North Carolina - Chapel Hill
Start Date
July 1, 2015
End Date
June 30, 2024
Administered By
Medicine, Infectious Diseases
Awarded By
University of North Carolina - Chapel Hill
Start Date
July 1, 2015
End Date
June 30, 2024